Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance.
Clinical Benefit
| Substantial |
The transparency Committee considers that the actual benefit of ARAVA continues to be substantial in the indications in the Marketing Authorisation. |
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
3nKeqqRkQ9C01GrS
